Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02667730
Other study ID # 2013-12-126-004-0001
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date June 2015
Est. completion date December 2021

Study information

Verified date February 2024
Source Canadian Department of National Defense
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this 4-arm pragmatic randomized control trial, the investigators hope to decipher whether the use of non-opioid analgesics (naproxen, celecoxib, acetaminophen) in addition to standardized physiotherapy during the acute phase of grade I-II ankle injuries will result in functional differences compared to standardized physiotherapy alone


Description:

Background Ankle sprains occur frequently in the Canadian Armed Forces (CAF) population and account for a significant proportion of lost work time. Equally significant is the use of analgesics (NSAID or non-NSAID) (NSAID = non steroidal anti-inflammatory drug) in the CAF population. Existing literature suggests that the rate and extent of soft tissue healing may be adversely affected by use of some analgesics, particularly non-steroidal anti-inflammatory agents (NSAIDs), when these are used immediately following joint injury. There have been two postulated mechanisms for this observation: the first being that inflammatory markers are required in the regeneration process; the second is that the diminished pain level as a result of analgesic use encourages overuse of the injured tissue. Unfortunately, the science is far from conclusive, since much of it is derived based on isolated exercises, conducted in experimental settings, in older populations, or extrapolated from biomarkers that have not been validated for clinical relevance. While there is no current standard of practice regarding the use of pain relievers following ankle injury, this practice continues to be widespread in the CAF. Goal The proposed study aims to clarify whether three commonly used non-opioid pain relievers provide additional benefit or delay improvement in ankle function following mild ankle sprains, when compared to standardized physiotherapy treatment alone. The three agents investigated will be 1) the non-steroid anti-inflammatory drug naproxen, 2) the selective anti-inflammatory celecoxib, and 3) the centrally-acting analgesic acetaminophen. Methods Patients presenting to the health clinic at Garrison Petawawa with acute ankle injuries will be screened for study eligibility. All individuals who elect to participate in this study will be referred for standardized physiotherapy treatment, which will be administered according to study protocol. Participants will also be randomized to one of four analgesic treatment groups (i.e., naproxen, celecoxib, acetaminophen, or non-pharmacological measures only), with stratification for grade of ankle injury. Physiotherapists who are blinded to analgesic treatment allocation will evaluate participants' ankle function at 72 hours, 2 weeks, 3 months and 1 year post-injury, using previously validated tests. Pharmacists will assess response to drug therapy, side effects, and use of rescue medications at day 7 following enrollment. Occurrence of repeat ankle injuries and health resource consumption (i.e., specialist visits and diagnostic imaging) will also be assessed for the year following index injury. Risks This study is intended to be low risk to participants as it is designed to closely mirror existing practices for such injuries. All medications used in this study are indicated for soft tissue injuries and their respective dosages/frequencies/durations aligned with manufacturer recommendations. The physiotherapy intervention was developed by Dr. Eric Robitaille. It has been used in previous studies and is currently in use in the CAF. The investigators do not expect the risk of injury to be higher than that associated with existing practices for ankle injuries. Benefits Participants are expected to benefit from the direct application of a standardized physiotherapy treatment protocol for overall management of their condition as well as the pain relief from the analgesic options. The results of this study are expected to generate new information that can be readily applied to patient care, specifically in treating a frequently-occurring soft tissue injury in the CAF population.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date December 2021
Est. primary completion date May 2019
Accepts healthy volunteers No
Gender All
Age group 17 Years to 60 Years
Eligibility Inclusion Criteria: - Acquired acute ankle injury (injured less than 48 hours ago); - Clinical diagnosis of a Grade I or II ankle sprain - Is eligible to receive comprehensive medical care from Garrison Petawawa Exclusion Criteria: - Diagnosis of ankle fracture or ligament rupture - Has planned release from the Canadian Armed Forces within one year; - Documented restrictions on military duties - Has known intolerance or documented adverse reaction to acetaminophen or naproxen or celecoxib - Documented history of liver or kidney problems - pregnant or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Acetaminophen
Acetaminophen 500 mg four times daily for 7 days
Naproxen
naproxen 500mg twice daily for 7 days
Celecoxib
celecoxib 100mg twice daily
Other:
physiotherapy only
physiotherapy only (no drug)

Locations

Country Name City State
Canada 2 Fd Amb medical clinic Petawawa Ontario

Sponsors (1)

Lead Sponsor Collaborator
Canadian Department of National Defense

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ankle Function on FAAM Foot and Ankle Abilities Measure 3 months
Secondary Pain on visual analogue scale (VAS) visual analogue scale 3 months
Secondary Mobility on Wall Lunge wall lunge test for ankle mobility 3 months
Secondary Laxity on anterior drawer test test for laxity 3 months
Secondary Proprioception on SEBT star excursion balance test 3 months
Secondary composite of health resource consumption # of orthopedic specialist consults, diagnostics, patient encounters for MSK reasons, # of days off work 1 year
See also
  Status Clinical Trial Phase
Terminated NCT05009342 - Evaluation of Functional Outcomes at 2 Months According to Therapeutic Management, in Trauma With Low-grade Osteo-ligamentous Ankle Injury in Children N/A
Recruiting NCT04899778 - Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes Phase 4
Not yet recruiting NCT05060900 - Hand Ligament Reconstructions With Knee Collateral Ligament Allografts N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT03479775 - Muscle Function and Traumatic Knee Injury in Sports
Not yet recruiting NCT05991557 - Peroneus Longus Graft :Effect in Foot and Ankle Function N/A
Recruiting NCT06050005 - Knee Functionality Recovery Indicators in Athletes Submitted to Ligamentoplasty of the Anterior Cruciate Ligament N/A
Not yet recruiting NCT05285020 - Antigravity Treadmill With Alter G on the Postural Stability of Traumatic Lower Limb Injuries N/A
Recruiting NCT03643926 - Arthroscopic Versus Open Brostrom for Ankle Instability N/A
Completed NCT04459910 - Medial and Lateral Combined Ligament Arthroscopic Repair for Multidirectional Ankle Instability: Case Series
Completed NCT02035774 - A Novel Selective Block of the Suprascapular Nerve Phase 4
Not yet recruiting NCT03390920 - Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions N/A
Completed NCT03747198 - Methylsulfonylmethane on Knee Laxity N/A
Completed NCT04310956 - A RCT for Y-Knot All-suture Anchor in Ankle Ligaments Injury Repair N/A
Completed NCT05220969 - Total Genotype Score, Growth, Maturation and Loading Exposure as Risk Factors for Injury in Elite Male Youth Football
Recruiting NCT05188391 - A New Method for Deltoid Ruptures: Gap Sign N/A
Recruiting NCT04348253 - Danish Multicenter Scapholunate Ligament Study N/A